Literature DB >> 18346206

Genetic inactivation of p62 leads to accumulation of hyperphosphorylated tau and neurodegeneration.

J Ramesh Babu1, M Lamar Seibenhener, Junmin Peng, Anna-Lena Strom, Robert Kemppainen, Nancy Cox, Haining Zhu, Michael C Wooten, María T Diaz-Meco, Jorge Moscat, Marie W Wooten.   

Abstract

The signaling adapter p62 plays a coordinating role in mediating phosphorylation and ubiquitin-dependent trafficking of interacting proteins. However, there is little known about the physiologic role of this protein in brain. Here, we report age-dependent constitutive activation of glycogen synthase kinase 3beta, protein kinase B, mitogen-activated protein kinase, and c-Jun-N-terminal kinase in adult p62(-/-) mice resulting in hyperphosphorylated tau, neurofibrillary tangles, and neurodegeneration. Biochemical fractionation of p62(-/-) brain led to recovery of aggregated K63-ubiquitinated tau. Loss of p62 was manifested by increased anxiety, depression, loss of working memory, and reduced serum brain-derived neurotrophic factor levels. Our findings reveal a novel role for p62 as a chaperone that regulates tau solubility thereby preventing tau aggregation. This study provides a clear demonstration of an Alzheimer-like phenotype in a mouse model in the absence of expression of human genes carrying mutations in amyloid-beta protein precursor, presenilin, or tau. Thus, these findings provide new insight into manifestation of sporadic Alzheimer disease and the impact of obesity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18346206     DOI: 10.1111/j.1471-4159.2008.05340.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  105 in total

Review 1.  Selective autophagy mediated by autophagic adapter proteins.

Authors:  Terje Johansen; Trond Lamark
Journal:  Autophagy       Date:  2011-03       Impact factor: 16.016

Review 2.  Autophagy and the ubiquitin-proteasome system: collaborators in neuroprotection.

Authors:  Natalia B Nedelsky; Peter K Todd; J Paul Taylor
Journal:  Biochim Biophys Acta       Date:  2008-10-10

Review 3.  Autophagy: regulation and role in development.

Authors:  Amber N Hale; Dan J Ledbetter; Thomas R Gawriluk; Edmund B Rucker
Journal:  Autophagy       Date:  2013-07       Impact factor: 16.016

Review 4.  Ubiquitin/proteasome pathway impairment in neurodegeneration: therapeutic implications.

Authors:  Qian Huang; Maria E Figueiredo-Pereira
Journal:  Apoptosis       Date:  2010-11       Impact factor: 4.677

5.  Autophagy and p62 in cardiac proteinopathy.

Authors:  Qingwen Zheng; Huabo Su; Mark J Ranek; Xuejun Wang
Journal:  Circ Res       Date:  2011-06-09       Impact factor: 17.367

6.  Age-associated oxidative damage to the p62 promoter: implications for Alzheimer disease.

Authors:  Yifeng Du; Michael C Wooten; Marla Gearing; Marie W Wooten
Journal:  Free Radic Biol Med       Date:  2008-11-21       Impact factor: 7.376

Review 7.  P62/SQSTM1 at the interface of aging, autophagy, and disease.

Authors:  Alessandro Bitto; Chad A Lerner; Timothy Nacarelli; Elizabeth Crowe; Claudio Torres; Christian Sell
Journal:  Age (Dordr)       Date:  2014-02-21

Review 8.  Mechanisms of Selective Autophagy in Normal Physiology and Cancer.

Authors:  Joseph D Mancias; Alec C Kimmelman
Journal:  J Mol Biol       Date:  2016-03-04       Impact factor: 5.469

Review 9.  The ubiquitin proteasome system in neuropathology.

Authors:  Norman L Lehman
Journal:  Acta Neuropathol       Date:  2009-07-14       Impact factor: 17.088

10.  Frequency of ubiquitin and FUS-positive, TDP-43-negative frontotemporal lobar degeneration.

Authors:  Harro Seelaar; Kirsten Y Klijnsma; Inge de Koning; Aad van der Lugt; Wang Zheng Chiu; Asma Azmani; Annemieke J M Rozemuller; John C van Swieten
Journal:  J Neurol       Date:  2009-11-28       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.